2021
DOI: 10.17235/reed.2021.8334/2021
|View full text |Cite
|
Sign up to set email alerts
|

Sclerotherapy using polidocanol 2% foam in the treatment of haemorrhoidal disease �a single-center experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…Recently, Figueiredo et al ( 29 ) proposed sclerotherapy with 2% polidocanol foam in 243 patients with different grades of HDs. Despite several limitations as the average follow-up, there was no information about the sample size and the number of sessions used; certainly, it cannot be considered a reliable study, although it would be interesting to compare the results with 2% and 3% polidocanol foam in terms of bleeding recurrence, effectiveness, and postprocedure complications ( 30 ).…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Figueiredo et al ( 29 ) proposed sclerotherapy with 2% polidocanol foam in 243 patients with different grades of HDs. Despite several limitations as the average follow-up, there was no information about the sample size and the number of sessions used; certainly, it cannot be considered a reliable study, although it would be interesting to compare the results with 2% and 3% polidocanol foam in terms of bleeding recurrence, effectiveness, and postprocedure complications ( 30 ).…”
Section: Discussionmentioning
confidence: 99%